478 related articles for article (PubMed ID: 35679361)
1. CRISPR Modeling and Correction of Cardiovascular Disease.
Liu N; Olson EN
Circ Res; 2022 Jun; 130(12):1827-1850. PubMed ID: 35679361
[TBL] [Abstract][Full Text] [Related]
2. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
Zhang Y; Karakikes I
Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
[TBL] [Abstract][Full Text] [Related]
3. CRISPR and cardiovascular diseases.
Musunuru K
Cardiovasc Res; 2023 Mar; 119(1):79-93. PubMed ID: 35388882
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic applications of CRISPR RNA-guided genome editing.
Koo T; Kim JS
Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research.
Li ZH; Wang J; Xu JP; Wang J; Yang X
Mil Med Res; 2023 Mar; 10(1):12. PubMed ID: 36895064
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic genome editing in cardiovascular diseases.
Nishiga M; Qi LS; Wu JC
Adv Drug Deliv Rev; 2021 Jan; 168():147-157. PubMed ID: 32092381
[TBL] [Abstract][Full Text] [Related]
8. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
9. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
11. Genome editing of hPSCs: Recent progress in hPSC-based disease modeling for understanding disease mechanisms.
Choi DK; Kim YK; HoonYu J; Min SH; Park SW
Prog Mol Biol Transl Sci; 2021; 181():271-287. PubMed ID: 34127196
[TBL] [Abstract][Full Text] [Related]
12. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
13. Genome Editing for the Study of Cardiovascular Diseases.
Chadwick AC; Musunuru K
Curr Cardiol Rep; 2017 Mar; 19(3):22. PubMed ID: 28220462
[TBL] [Abstract][Full Text] [Related]
14. Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.
Musunuru K
J Am Coll Cardiol; 2017 Dec; 70(22):2808-2821. PubMed ID: 29191331
[TBL] [Abstract][Full Text] [Related]
15. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
16. Implications of CRISPR-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases.
Sheikh Beig Goharrizi MA; Ghodsi S; Memarjafari MR
Curr Probl Cardiol; 2023 May; 48(5):101603. PubMed ID: 36682390
[TBL] [Abstract][Full Text] [Related]
17. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9 therapies in experimental mouse models of cancer.
Estêvão D; Rios Costa N; da Costa RG; Medeiros R
Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
[TBL] [Abstract][Full Text] [Related]
19. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.
Li Y; Song YH; Liu B; Yu XY
Int J Cardiol; 2017 Jan; 227():191-193. PubMed ID: 27847153
[TBL] [Abstract][Full Text] [Related]
20. Advances in therapeutic application of CRISPR-Cas9.
Sun J; Wang J; Zheng D; Hu X
Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
